Delivery Order SPE2DB20D2014-SPE2DB25FC08X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,522.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for one package of Gvoke HypoGel 1 mg/0.2 mL auto-injector. The order is set to be completed by August 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,808.10 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) auto-injectors. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of GVOKE HypoGel auto-injectors (2-pack, 1 mg/0.2 ml dosage) with a ceiling value of $1,018.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,523.55 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.00 to AmerisourceBergen Drug Corp for GVOKE HypoKit 2-pack auto-injectors (1 mg/0.2 mL) on June 4, 2025, with completion scheduled for June 5, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The GVOKE HypoKit is a critical emergency medication delivery system used to treat severe hypoglycemia in...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC08XDelivery Order
The Defense Logistics Agency awarded a $2,540.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoOpen 2-pack auto-injectors (1 mg/0.2 mL) on June 2, 2025, with completion targeted for June 3, 2025. The order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that enables global pharmaceutical supply to military healthcare systems. This award carries no set-aside designation and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The GVOKE HypoOpen product is a glucagon auto-injector used for emergency treatment of severe hypoglycemia, representing the specialized medical supplies and emergency medications within the contractor's comprehensive pharmaceutical portfolio. As a competitively awarded delivery order under the DLA's broader pharmaceutical prime vendor framework, this contract demonstrates the contractor's capability to meet federal requirements for critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/2/25 |